Indian Headline News
Agency News

Alienkind – The Next Gen Cafe, bags a Pre-Series A round of $3.2 Million

Alienkind – The Next Gen Cafe, bags a Pre-Series A round of $3.2 Million

Alienkind, India’s Next-Gen brand, has raised $3.2 Million in a Pre-Series A round. The capital will support Alienkind’s next phase of growth, including expansion into new markets.The brand is also gearing up for a massive Series-A round in the coming few months.

The brand is at the intersection of design and culture. Built for a new generation of consumers. The brand is redefining the ecosystem through immersive spaces, category-defining products, and community-driven experiences. It is building for the consumers seeking brands that are an extension of their identity and personality.

The round is backed by existing investors like Prakash Sikaria, Founder of Super.money, Flipkart Senior VP Ravi Iyer, and Bain & Co. Global Innovation Head Arpan Sheth and others.

“Alienkind was built to break the shackles of the traditional food and beverage ecosystem. The traditional ecosystem was built around transactions. Alienkind was built to transcend them” added Vikram Kakkireni, Co-Founder of Alienkind.

The company is currently racing towards an ARR of $10 Million by the end of FY27 which is a reflection of what happens when a brand gets both the culture and the execution right. It is one of the fastest growing F&B brands India has witnessed, being one of the few brands to have scaled across cities within 16 months, celebrating massive hype. Its unique value proposition, competitive pricing, and strategic brand positioning have helped it carve out a distinctive identity in the market. The company is on a runway to build 100 stores by FY28 across top cities of the country.

Related posts

Group Pharmaceuticals Launches ‘Abledent’ – India’s First Inclusive Oral Care Ecosystem Designed for Real-World Needs

cradmin

Delta Group Proudly Co-Sponsors Zee 24 Taas Maharashtra Gaurav 2026; Felicitates Hon’ble CM Devendra Fadnavis

cradmin

Beyond Borders: ImmunoACT and India’s Emergence as one of the World’s Most Accessible CAR-T Destination

cradmin